Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiner, T. M.
Right arrow Articles by Cance, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiner, T. M.
Right arrow Articles by Cance, W. G.

Annals of Surgical Oncology, Vol 1, Issue 1 18-27, Copyright © 1994 by Society of Surgical Oncology


ARTICLES

Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors

T. M. Weiner, E. T. Liu, R. J. Craven and W. G. Cance
Department of Surgery, University of North Carolina School of Medicine, Chapel Hill.

BACKGROUND: The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas. METHODS: To characterize the protein tyrosine kinases that are expressed in human sarcomas, we used a polymerase chain reaction (PCR)-based method to construct kinase-specific cDNA libraries from low-grade and high-grade primary tumors. Thereafter, individual tyrosine kinase gene expression was assessed in a panel of sarcoma cell lines and primary tumors using Northern blotting and PCR. RESULTS: We identified 19 species of tyrosine kinase genes, including many growth factor receptors, the human homolog of the focal adhesion kinase (FAK) gene, and a novel trk-related kinase designated HGK2. Messenger RNA expression analyses showed relative overexpression of the two forms of the platelet-derived growth factor receptors (PDGFRs) with expression of the alpha form restricted to a subgroup of high-grad and metastatic sarcomas. We were unable to demonstrate coexpression of the PDGF isoforms in primary tumors that overexpressed the receptors, suggesting that a PDGF/PDGFR autocrine pathway may not be a central mechanism in the malignant transformation of sarcomas in vivo. FAK expression was observed in a variety of sarcomas, with increased levels in several high-grade and metastatic leiomyosarcomas. CONCLUSIONS: When grouped together by histologic cell type and grade, the expression data of the 19 kinases in primary tumors described a greater degree of heterogeneity than is generally appreciated by clinicopathologic classification schemes. This diversity suggests that sarcomas, even those that appear to be clinically similar, arise through a variety of molecular pathways involving tyrosine kinases.


This article has been cited by other articles:


Home page
Cancer Res.Home page
Q.-S. Zhu, W. Ren, B. Korchin, G. Lahat, A. Dicker, Y. Lu, G. Mills, R. E. Pollock, and D. Lev
Soft Tissue Sarcoma Cells Are Highly Sensitive to AKT Blockade: A Role for p53-Independent Up-regulation of GADD45{alpha}
Cancer Res., April 15, 2008; 68(8): 2895 - 2903.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
M. T. Frey, I. Y. Tsai, T. P. Russell, S. K. Hanks, and Y.-l. Wang
Cellular Responses to Substrate Topography: Role of Myosin II and Focal Adhesion Kinase
Biophys. J., May 15, 2006; 90(10): 3774 - 3782.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. R. van Ginkel, R. L. Gee, R. L. Shearer, L. Subramanian, T. M. Walker, D. M. Albert, L. F. Meisner, B. C. Varnum, and A. S. Polans
Expression of the Receptor Tyrosine Kinase Axl Promotes Ocular Melanoma Cell Survival
Cancer Res., January 1, 2004; 64(1): 128 - 134.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
V. M. Golubovskaya, S. Gross, A. S. Kaur, R. I. Wilson, L.-H. Xu, X. H. Yang, and W. G. Cance
Simultaneous Inhibition of Focal Adhesion Kinase and Src Enhances Detachment and Apoptosis in Colon Cancer Cell Lines
Mol. Cancer Res., August 1, 2003; 1(10): 755 - 764.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. L. Lark, C. A. Livasy, B. Calvo, L. Caskey, D. T. Moore, X. Yang, and W. G. Cance
Overexpression of Focal Adhesion Kinase in Primary Colorectal Carcinomas and Colorectal Liver Metastases: Immunohistochemistry and Real-Time PCR Analyses
Clin. Cancer Res., January 1, 2003; 9(1): 215 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Golubovskaya, L. Beviglia, L.-H. Xu, H. S. Earp III, R. Craven, and W. Cance
Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells
J. Biol. Chem., October 4, 2002; 277(41): 38978 - 38987.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W.-P. Lee, Y. Liao, D. Robinson, H.-J. Kung, E. T. Liu, and M.-C. Hung
Axl-Gas6 Interaction Counteracts E1A-Mediated Cell Growth Suppression and Proapoptotic Activity
Mol. Cell. Biol., December 1, 1999; 19(12): 8075 - 8082.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. G. Gervais, N. A. Thornberry, S. C. Ruffolo, D. W. Nicholson, and S. Roy
Caspases Cleave Focal Adhesion Kinase during Apoptosis to Generate a FRNK-like Polypeptide
J. Biol. Chem., July 3, 1998; 273(27): 17102 - 17108.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Tanaka, Y. Nagayama, T. Nakano, N. Takamura, H. Namba, S. Fukada, K. Kuma, S. Yamashita, and M. Niwa
Expression Profile of Receptor-Type Protein Tyrosine Kinase Genes in the Human Thyroid
Endocrinology, March 1, 1998; 139(3): 852 - 858.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society of Surgical Oncology.